Enzo biochem inc (ENZ)
CashFlow / TTM
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Oct'14Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Jul'11Apr'11Jan'11Oct'10
Cash flows from operating activities:
Net loss

1,543

822

2,489

2,112

-23,169

-15,662

-10,321

-4,463

-1,518

-1,670

-2,504

33,537

31,493

39,378

45,286

17,593

16,801

5,878

-2,285

-13,896

-11,444

-10,919

-9,977

-9,910

-15,225

-17,333

-18,237

-42,278

-39,919

-38,466

-39,269

-16,149

-14,842

-16,332

-12,960

0

0

0

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization of property, plant and equipment

2,296

2,254

2,194

2,161

2,127

2,136

2,138

2,134

2,106

2,084

2,078

2,113

2,127

2,151

2,163

2,108

2,064

2,039

2,019

2,016

2,046

2,081

2,131

2,240

2,375

2,520

2,615

2,665

2,676

2,668

2,817

2,984

3,036

3,053

2,962

0

0

0

Amortization of intangible assets

640

741

842

991

1,002

1,011

992

1,122

1,185

1,336

1,520

1,557

1,653

1,666

1,677

1,746

1,754

1,762

1,770

1,737

1,771

1,803

1,840

1,883

1,921

1,961

1,990

2,023

1,878

1,736

1,660

1,500

1,530

1,550

1,507

0

0

0

Provision for uncollectible accounts receivable

-

-

-

-

-

-

-

-

-

-

-

2,565

2,521

2,301

2,336

2,292

2,305

2,447

2,284

2,326

2,421

2,732

3,063

3,107

3,351

3,774

4,496

5,313

5,578

5,412

5,104

5,042

4,854

4,642

4,431

0

0

0

Deferred income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-60

-41

-61

-83

-104

-24

-16

-10

-18

-544

-566

-594

-759

-1,953

-1,943

-1,925

-1,762

54

11

15

17

0

0

0

Share-based compensation charges

934

923

939

921

926

843

813

847

852

885

831

756

696

565

525

480

447

442

429

416

585

589

594

605

456

506

545

561

590

648

719

774

833

935

1,049

0

0

0

Accrual for share-based 401(k) employer match expense

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share-based 401(k) employer match expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

666

649

643

606

659

690

0

0

0

Deferred revenue recognized

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-38

0

0

0

Accrual for share based 401(k) employer match

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign exchange (gain) loss

-15

26

-493

-1,085

-1,229

-579

-475

892

1,491

627

476

-610

-444

-577

-357

-38

-427

-371

-664

-790

-585

-420

304

508

94

147

127

-317

157

-313

-538

0

0

0

-

-

-

-

Foreign currency transaction loss (gain)

-15

26

-493

-1,085

-1,229

-579

-475

892

1,491

627

476

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Foreign currency transaction loss (gain)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Accounts receivable

-2,781

-2,982

-2,404

-2,764

-3,180

-1,514

-1,915

-3,479

-1,907

-394

469

4,943

5,009

3,565

4,791

4,103

3,431

2,897

2,003

1,682

2,415

1,429

3,224

2,204

2,640

3,473

2,606

4,696

4,759

4,896

4,210

5,238

5,750

4,369

6,537

0

0

0

Other receivables - settlements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,650

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

-50

-47

572

612

237

524

413

-48

100

-192

-92

194

-248

-378

-466

-1,001

-825

-834

-1,151

-900

-846

-518

-159

-358

-90

382

-60

-17

-114

-372

-199

-222

452

-236

178

0

0

0

Prepaid expenses and other assets

-54

114

182

628

793

935

1,177

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other

-

-

-

-

-

-

-

-

-

-

-

38

114

136

-169

-278

282

-152

108

33

-348

-195

-336

-24

-267

33

97

-241

-179

-213

-356

268

372

252

432

0

0

0

Accounts payable – trade

115

1,178

-2,508

-2,124

-1,824

-2,429

-887

-1,152

-532

218

515

248

648

-101

1,103

1,747

2,510

2,233

394

-120

-1,994

-1,636

-226

-1,755

-152

864

-514

1,922

1,144

1,247

1,031

13

720

-438

1,462

0

0

0

Accrued liabilities, other current liabilities and other liabilities

2,287

-729

-2,148

-1,798

-1,650

1,085

2,901

2,655

2,880

404

-1,898

-3,201

-5,039

-4,237

-3,464

-1,807

-1,335

-1,653

-1,923

-238

3,189

3,891

3,293

1,851

-599

-166

1,975

2,944

2,834

2,725

2,056

0

0

0

-

-

-

-

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Total adjustments

10,047

8,122

2,317

3,609

4,824

4,128

7,586

5,677

4,980

4,393

2,299

691

-1,263

262

7,840

3,881

6,035

6,330

-1,415

6,763

7,979

9,775

8,280

5,676

5,078

5,486

8,221

34,186

32,927

33,319

33,297

0

0

0

-

-

-

-

Net cash used in operating activities

11,590

8,944

4,806

5,721

-18,345

-11,534

-2,735

1,214

3,462

2,723

-205

34,228

30,230

39,640

53,126

21,474

22,836

12,208

-3,700

-7,133

-3,465

-1,144

-1,697

-4,234

-10,147

-11,847

-10,016

-8,092

-6,992

-5,147

-5,972

-9,556

-9,700

-8,847

-8,326

0

0

0

Cash flows from investing activities:
Capital expenditures

1,572

7,994

8,126

7,816

7,810

1,833

1,888

1,955

2,130

1,700

1,753

1,565

1,276

1,539

1,530

2,004

2,073

2,024

1,783

1,436

1,047

768

838

786

842

1,031

988

1,157

1,410

1,403

1,364

1,181

1,194

1,233

1,223

0

0

0

Security deposits and other

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of short term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

58,497

68,617

113,230

148,841

182,453

0

0

0

Purchases of short term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

48,497

60,809

101,422

136,034

167,646

0

0

0

Increase (decrease) in security deposits and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

0

0

0

-

-

-

-10

5

135

13

81

17

-45

-78

37

-25

0

0

0

-

-

-

-

Security deposits and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net cash used in investing activities

-1,572

-7,385

-8,126

-7,821

-7,856

-2,498

-1,944

-2,008

-2,138

-1,696

-1,749

-1,540

-1,258

-1,536

-1,512

-1,973

-2,040

-1,983

-1,752

-1,478

-1,014

-778

-833

-651

-829

-950

-971

8,798

8,512

7,484

7,461

5,485

9,544

11,475

13,539

0

0

0

Cash flows from financing activities:
Net proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,688

8,774

12,639

12,180

11,542

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from borrowing under mortgage agreement

-

-

-

-

-

-

-

-

-

-

40,694

63,231

86,196

91,716

89,880

90,586

89,648

88,733

88,632

87,377

85,562

85,998

78,814

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Repayments under mortgage agreement and finance leases

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments under mortgage agreement, capital leases or Credit Agreement

-

-

-

-

-

-

-

-

-

-

42,250

65,230

89,209

92,729

91,336

91,599

89,648

88,733

88,632

87,377

85,462

86,630

79,065

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Installment loan payments

-

-

-

-

-

-

-

-

-

-521

-566

-569

-630

-586

-565

-571

-491

-473

-463

-410

-423

-393

-374

-367

-372

-342

-274

-236

-169

-149

-154

0

0

0

-

-

-

-

Cost to obtain loan

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

167

221

342

253

886

1,125

1,092

1,105

453

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

-492

4,056

4,193

4,377

4,495

-32

559

688

660

-1,415

-1,669

-2,385

-3,548

-1,503

-1,931

-1,517

922

3,893

6,225

8,364

12,316

11,155

10,917

13,923

8,610

6,812

4,815

-233

-169

-149

-154

0

0

0

-

-

-

-

Effect of exchange rate changes on cash and cash equivalents

-2

1

-18

-31

-34

-8

-6

35

57

23

13

-36

-13

-29

-15

1

-48

-67

-119

-182

-112

-68

61

122

-36

10

103

-76

83

-164

-420

-218

-108

98

257

0

0

0

Decrease in cash and cash equivalents and restricted cash

9,524

5,616

855

2,246

-21,740

-14,072

-4,126

-71

2,041

-365

-3,610

30,267

25,411

36,572

49,668

17,985

21,670

14,051

654

-429

7,725

9,165

8,448

9,160

-2,402

-5,975

-6,069

397

1,434

2,024

915

-4,462

-400

2,625

5,402

0

0

0